Roffman Miller Associates’s CVS Health CVS Stock Holding History

Roffman Miller Associates’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-2,915	Closed	-$229K	–	75
2018 Q3	$229K	Sell	2,915 -2,009	-41%	-$144K	0.03%	80
2018 Q2	$317K	Sell	4,924 -66,793	-93%	-$4.4M	0.04%	60
2018 Q1	$4.46M	Sell	71,717 -70,924	-50%	-$5.09M	0.57%	42
2017 Q4	$10.3M	Sell	142,641 -9,311	-6%	-$677K	1.28%	34
2017 Q3	$12.4M	Buy	151,952 +3,793	+3%	+$300K	1.63%	33
2017 Q2	$11.9M	Buy	148,159 +8,628	+6%	+$681K	1.63%	34
2017 Q1	$11M	Buy	139,531 +7,983	+6%	+$637K	1.55%	34
2016 Q4	$10.4M	Buy	131,548 +5,235	+4%	+$424K	1.57%	34
2016 Q3	$11.2M	Buy	126,313 +19,145	+18%	+$1.81M	1.82%	32
2016 Q2	$10.3M	Buy	107,168 +33,443	+45%	+$3.33M	1.68%	32
2016 Q1	$7.65M	Buy	+73,725	New	+$7.17M	1.31%	35

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Roffman Miller Associates's CVS Position: Q4 2018 in Review

Roffman Miller Associates sold out of CVS Health (CVS) in Q4 2018, closing a stake of 2,915 shares — an estimated $229K sold.

Roffman Miller Associates first reported a position in CVS in Q1 2016 and held it in 11 quarters. The position peaked at $12.4M in Q3 2017. 1,779 funds tracked by Wall St. Rank hold CVS as of Q4 2018.

Roffman Miller Associates reported no remaining CVS Health position as of Q4 2018 after selling out during the quarter.
Roffman Miller Associates sold 2,915 CVS Health shares in Q4 2018, an estimated $229K.
Roffman Miller Associates first reported a position in CVS Health in Q1 2016 and held it in 11 quarters.
Roffman Miller Associates's CVS Health position peaked at $12.4M in Q3 2017.
1,779 funds tracked by Wall St. Rank held CVS Health as of Q4 2018.

Based on Roffman Miller Associates's 13F filing for Q4 2018, filed 11 Feb 2019.